ReviewCurrent atherosclerosis reports2020

Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?

Jean-Charles Fruchart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.